Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
The American College of Cardiology and American Heart Association guidelines do not currently recommend GLP-1 receptor agonists as primary lipid-lowering agents
Yes, Medicare and Medicaid patients can use LillyDirect self-pay if paying cash out of pocket (not billing to your government plan)
Lyophilized form is preferred for long-term storage
The Precision Peptide Genetic Test may help provide context about your individual genetic predisposition in GLP-1 and GIP receptor pathways
Study Objectives To evaluate if semaglutide 2.4 mg subcutaneously once weekly is superior to placebo when added to standard of care for preventing major adverse cardiovascular events in patients with established CVD and overweight or obesity but without diabetes
US$ 28.13
.png)
US$ 23.91
US$ 21.50
US$ 24.46
